ARKG Investment Tracker position change: Increased position in Twist Bioscience Corp by 12,160 shares, the number of shares held increased 0.58% compared to the previous period and now represents 8.48% of the total position.

ARKG Investment Tracker position change: Increased position in Illumina by 820 shares, the number of shares held increased 0.58% compared to the previous period and now represents 1.15% of the total position.

ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 23,307 shares, the number of shares held increased 1.2% compared to the previous period and now represents 4.09% of the total position.

ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 67,925 shares, the number of shares held increased 0.58% compared to the previous period and now represents 7.22% of the total position.

ARKG Investment Tracker position change: Increased position in Natera by 2,160 shares, the number of shares held increased 0.58% compared to the previous period and now represents 5.9% of the total position.

ARKG Investment Tracker position change: Increased position in Amgen by 862 shares, the number of shares held increased 1.53% compared to the previous period and now represents 1.72% of the total position.

ARKG Investment Tracker position change: Increased position in Veeva by 290 shares, the number of shares held increased 0.58% compared to the previous period and now represents 1.18% of the total position.

ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 320,078 shares, the number of shares held increased 11.24% compared to the previous period and now represents 2.74% of the total position.

ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 140 shares, the number of shares held increased 0.58% compared to the previous period and now represents 1.29% of the total position.

ARKG Investment Tracker position change: Increased position in Tempus AI by 8,830 shares, the number of shares held increased 0.58% compared to the previous period and now represents 7.21% of the total position.

ARKG Investment Tracker position change: Increased position in Incyte by 890 shares, the number of shares held increased 0.58% compared to the previous period and now represents 0.96% of the total position.

ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 372,339 shares, the number of shares held increased 3.39% compared to the previous period and now represents 1.44% of the total position.

ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 12,165 shares, the number of shares held increased 0.58% compared to the previous period and now represents 5.97% of the total position.

ARKG Investment Tracker position change: Increased position in Intellia Therapeutics by 16,575 shares, the number of shares held increased 0.58% compared to the previous period and now represents 2.6% of the total position.

ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 70 shares, the number of shares held increased 0.56% compared to the previous period and now represents 0.8% of the total position.

ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 5,305 shares, the number of shares held increased 0.58% compared to the previous period and now represents 2.91% of the total position.

ARKG Investment Tracker position change: Increased position in Veracyte by 6,640 shares, the number of shares held increased 0.58% compared to the previous period and now represents 3.9% of the total position.

ARKG Investment Tracker position change: Increased position in CRISPR Therapeutics AG by 11,275 shares, the number of shares held increased 0.58% compared to the previous period and now represents 8.35% of the total position.

ARKG Investment Tracker position change: Increased position in Guardant Health Inc. by 7,485 shares, the number of shares held increased 0.58% compared to the previous period and now represents 6.19% of the total position.

ARKG Investment Tracker position change: Decreased position in Natera by 18,144 shares, the number of shares held decreased 4.63% compared to the previous period and now represents 6.03% of the total position.